154 related articles for article (PubMed ID: 27186085)
1. Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose-insulin homeostasis in animal models.
Mastan SK; Kumar KE
J Exp Pharmacol; 2010; 2():1-11. PubMed ID: 27186085
[TBL] [Abstract][Full Text] [Related]
2. Influence of non-nucleoside reverse transcriptase inhibitors (efavirenz and nevirapine) on the pharmacodynamic activity of gliclazide in animal models.
Mastan S; Kumar KE
Diabetol Metab Syndr; 2009 Oct; 1(1):15. PubMed ID: 19825151
[TBL] [Abstract][Full Text] [Related]
3. Influence of curcumin on the pharmacodynamics and pharmacokinetics of gliclazide in animal models.
Vatsavai LK; Kilari EK
J Exp Pharmacol; 2016; 8():69-76. PubMed ID: 27895517
[TBL] [Abstract][Full Text] [Related]
4. Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits.
Kura RR; Kilari EK; Shaik M
PeerJ; 2018; 6():e4798. PubMed ID: 29844963
[TBL] [Abstract][Full Text] [Related]
5. Influence of nicorandil on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits.
Satyanarayana S; Kilari EK
Mol Cell Biochem; 2006 Oct; 291(1-2):101-5. PubMed ID: 16715184
[TBL] [Abstract][Full Text] [Related]
6. Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models.
Vatsavai LK; Kilari EK
J Ayurveda Integr Med; 2018; 9(3):183-189. PubMed ID: 29103851
[TBL] [Abstract][Full Text] [Related]
7. [Insulin resistance in HIV-infected patients receiving long-term therapy with efavirenz, lopinavir/ritonavir and atazanavir].
Bernal E; Masiá M; Padilla S; Ramos JM; Martín-Hidalgo A; Gutiérrez F
Med Clin (Barc); 2007 Jul; 129(7):252-4. PubMed ID: 17683706
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral Therapy in the Real World : Population-Based Pharmacoeconomic Analysis of Administration of Anti-HIV Regimens to 990 Patients.
Sabbatani S; Manfredi R; Biagetti C; Chiodo F
Clin Drug Investig; 2005; 25(8):527-35. PubMed ID: 17532696
[TBL] [Abstract][Full Text] [Related]
9. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
Poirier JM; Robidou P; Jaillon P
Ther Drug Monit; 2005 Apr; 27(2):186-92. PubMed ID: 15795650
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of glucose metabolism disorders among People Living with HIV on combination antiretroviral therapy.
Tadesse WT; Adankie BT; Shibeshi W; Amogne W; Aklillu E; Engidawork E
PLoS One; 2022; 17(1):e0262604. PubMed ID: 35045105
[TBL] [Abstract][Full Text] [Related]
11. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
12. Long-term evaluation of glucose homeostasis in a cohort of HAART-treated HIV-infected children: a longitudinal, observational cohort study.
Viganò A; Brambilla P; Pattarino G; Stucchi S; Fasan S; Raimondi C; Cerini C; Giacomet V; Zuccotti GV; Bedogni G
Clin Drug Investig; 2009; 29(2):101-9. PubMed ID: 19133705
[TBL] [Abstract][Full Text] [Related]
13. Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients.
Dailly E; Tribut O; Tattevin P; Arvieux C; Perré P; Raffi F; Jolliet P
Eur J Clin Pharmacol; 2006 Jul; 62(7):523-6. PubMed ID: 16763827
[TBL] [Abstract][Full Text] [Related]
14. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
Portha B; Serradas P
Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
[TBL] [Abstract][Full Text] [Related]
15. Interactions between etonogestrel-releasing contraceptive implant and 3 antiretroviral regimens.
Kreitchmann R; Stek A; Best BM; Capparelli E; Wang J; Shapiro D; Chakhtoura N; Mirochnick M; Eke AC;
Contraception; 2022 Jan; 105():67-74. PubMed ID: 34407424
[TBL] [Abstract][Full Text] [Related]
16. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.
Daar ES; Tierney C; Fischl MA; Sax PE; Mollan K; Budhathoki C; Godfrey C; Jahed NC; Myers L; Katzenstein D; Farajallah A; Rooney JF; Pappa KA; Woodward WC; Patterson K; Bolivar H; Benson CA; Collier AC;
Ann Intern Med; 2011 Apr; 154(7):445-56. PubMed ID: 21320923
[TBL] [Abstract][Full Text] [Related]
17. The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers.
Aarnoutse RE; Grintjes KJ; Telgt DS; Stek M; Hugen PW; Reiss P; Koopmans PP; Hekster YA; Burger DM
Clin Pharmacol Ther; 2002 Jan; 71(1):57-67. PubMed ID: 11823758
[TBL] [Abstract][Full Text] [Related]
18. Drug-drug Interaction between Pravastatin and Gemfibrozil (Antihyperlipidemic) with Gliclazide (Antidiabetic) in Rats.
Sultanpur C; Satyanarayana S; Reddy N; Kumar K; Kumar S
J Young Pharm; 2010 Apr; 2(2):152-5. PubMed ID: 21264118
[TBL] [Abstract][Full Text] [Related]
19. Comparison of beta-cell function after long-term treatment with either insulin, insulin plus gliclazide or gliclazide in neonatal streptozotocin-induced non-insulin-dependent diabetic rats.
Kawai K; Suzuki S; Murayama Y; Watanabe Y; Yamashita K
Diabetes Res Clin Pract; 1991 Jul; 12(3):163-72. PubMed ID: 1832376
[TBL] [Abstract][Full Text] [Related]
20. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
Ther Drug Monit; 2002 Jun; 24(3):417-24. PubMed ID: 12021635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
